Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

Hycamtin approved for treatment of relapsed small cell lung cancer

Oct. 17, 2007

Partial hold on clinical development of Telcyta removed

Oct. 17, 2007

Preclinical safety study of GSAO, a potential anticancer compound

Oct. 17, 2007

Masitinib mesylate safe and effective in indolent systemic mastocytosis

Oct. 17, 2007

Covidien and BioSynthema sign agreement for nuclear medicine cancer therapy

Oct. 17, 2007

Diindolylmethane a possible alternative to surgery for cervical dysplasia

Oct. 17, 2007

Clinical data on PEP-005 topical gel for skin cancers presented

Oct. 16, 2007

Series B financing by Metastatix to support cancer drug clinical trials

Oct. 16, 2007

Partial response rate reported in Davant phase II trial for colorectal cancer

Oct. 16, 2007

CP-4126 well tolerated in solid tumor patients

Oct. 16, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 4, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...